These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 366615)

  • 1. Leukemia in AKR mice: a defined suppressor cell population expressing membrane-associated DNA.
    Russell JL; Golub ES
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6211-4. PubMed ID: 366615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface DNA in immunosuppression in AKR leukemia.
    Russell JL; Golub ES
    J Immunol; 1980 Nov; 125(5):2328-33. PubMed ID: 7000899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia in AKR mice. I. Effects of leukemic cells on antibody-forming potential of syngeneic and allogeneic normal cells.
    Roman JM; Golub ES
    J Exp Med; 1976 Mar; 143(3):482-96. PubMed ID: 942993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a soluble suppressor factor(s) in the serum of AKR mice bearing lymphocytic leukemia.
    Simon JD; Freed BM; Davignon D; Albala MM
    Cell Immunol; 1983 Nov; 82(1):163-73. PubMed ID: 6605807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to sheep red cells in AKR mouse leukemia.
    Ram MD; Kohn RR; Novak D
    Am J Pathol; 1973 Jul; 72(1):39-52. PubMed ID: 4719527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia in AKR mice. II. Two modes of suppression of in vitro antibody formation by leukemic cells.
    Roman JM; Golub ES
    Cell Immunol; 1978 Oct; 40(2):316-25. PubMed ID: 719762
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuclease activity in leukemia altered lymphoid tissue].
    Svirnovskiĭ AI; Shimanskaia TV; Levin VI; Bakun AV
    Vopr Med Khim; 1978; 24(4):479-83. PubMed ID: 685191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulatory effect on DNA synthesis of thymus and spleen extract from leukemic AKR mice.
    Ebbesen P; Olsson L
    J Cancer Res Clin Oncol; 1981; 100(1):105-7. PubMed ID: 7240341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suppressive effect of bone marrow cells from normal and leukemic mice on antibody production in culture of spleen cells in vitro].
    Sidorovich IG; Pcheliniev SIu; Khalmov RM
    Biull Eksp Biol Med; 1980; 89(1):36-8. PubMed ID: 6991020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential leukemic cells among bone marrow cells of young AKR/J mice.
    Haran-Ghera N
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2923-6. PubMed ID: 6967216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
    Cerny J; Stiller RA
    J Immunol; 1975 Oct; 115(4):943-9. PubMed ID: 170339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering of leukemia in thymectomized AKR mice by a membrane fraction of thymic stroma.
    Fournier M; Potworowski EF
    Thymus; 1983 Mar; 5(2):89-94. PubMed ID: 6602405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine leukemia. Proposed role for gangliosides in immune suppression.
    Krishnaraj R; Lengle EE; Kemp RG
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):89-98. PubMed ID: 6211363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia.
    Meruelo D; Flieger N; Smith D; McDevitt HO
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2178-82. PubMed ID: 6769122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts.
    Rodey GE; Sprader JC; Bortin MM
    Cancer Res; 1974 Jun; 34(6):1289-94. PubMed ID: 4275007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.